go back

Indiana rates for HCPCS M0241

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses

Insurance Carrier
CareSource
Facility/Professional
Facility
Modifier
Low / Median / High Price
$954.79 / $954.79 / $1,166.96
CareSource
Facility/Professional
Professional
Modifier
Low / Median / High Price
$954.79 / $954.79 / $1,193.48